Spain’s pharmaceutical lobby is negotiating a plan to sell state-guaranteed securities backed by €5.4 billion ($7.1 billion) of unpaid bills, according to a Bloomberg report.

The group is looking to bundle outstanding debt into a vehicle that would issue securities guaranteed by the central government.

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.